SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs agreement to acquire nationwide low-band spectrum has put Starlinks push into U.S. mobile service and competition with established carriers at the center of discussion. Traders are split between viewing it as a major growth opportunity and questioning the cost, timeline, and ability to compete; concerns about newly unlocked shares adding selling pressure are also weighing on sentiment.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Managements AI infrastructure expansion and GPU deployment plans have put the focus on whether Gorilla can turn its large contract pipeline into operating revenue. Traders are split between optimism about project execution and analyst interest, and concern over unresolved financing, potential dilution, and the companys record of meeting milestones.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

A Nikkei report that Apple cut iPhone 18 Pro component orders amid weaker-than-expected demand and higher prices is driving discussion. Traders are split between viewing it as a sign of soft demand and dismissing it as an unverified or routine supply adjustment, with some suggesting buyers may be shifting to the iPhone Duo.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Deltas quarterly results missed profit expectations and included a lower full-year earnings outlook as fuel costs surged, weighing on shares. Traders are split: bears focus on the fuel-driven guidance cut, while bulls point to resilient travel demand and fare strength.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum is drawing attention after CEO Michael Hurlston said its optical components are sold out through early 2029, underscoring strong AI data-center demand and supply constraints. Bulls see a durable growth signal, while skeptics question the forecast and contract certainty and warn that valuation and a possible AI-spending slowdown leave the shares vulnerable.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

SpaceXs agreement to acquire low-band spectrum and expand Starlink Mobile toward a U.S. wireless carrier has put AT&T under pressure amid fears of increased competition. Traders are divided between seeing the selloff as an overreaction because a competing network would take years and have capacity limits, and viewing Starlink as a longer-term threat; some are buying the dip while others remain cautious.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs agreement to acquire Grain Managements 800 MHz spectrum has focused attention on the prospect of Starlink Mobile competing more directly with T-Mobile and other U.S. carriers. Traders are split between viewing the move as a serious long-term competitive threat and calling the selloff an overreaction, arguing that building capacity and coverage to rival terrestrial networks will take substantial time and infrastructure.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the following business segments: Consumer and Business. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

SpaceXs planned acquisition of low-band spectrum has renewed concerns that Starlink Mobile could compete with Verizon and other major wireless carriers, weighing on the sector. Traders disagree on the threats scale: some see a future challenge to carrier customers and pricing, while others view the selloff as excessive given the years and infrastructure needed to build a competitive network.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

The 2027 Medicare Advantage star ratings are a key topic: three UnitedHealthcare contracts earned five stars, but traders are comparing UNHs muted response with Humanas rally after improved ratings and debating whether UNHs results are better than expected. With quarterly earnings approaching, the community is split between hopes for a rebound and concern about the stocks extended decline and volatility.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

CMSs 2027 Medicare Advantage ratings lifted Humanas largest contract to four stars, restoring eligibility for 2028 quality bonuses; the ratings recovery and analyst upgrades fueled bullish discussion, though some traders questioned the sharp rally and positioned for a pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SRZN .....Saturday AAO = binary moment. 
 
Merck’s Wnt data decides srzn fate for Monday: 
• Flop / toxic safety tables ➡️ dump to $10-$12 (PIPE floor) 
• Home run on vessel reperfusion ➡️ squeeze to $50+ 
 
Zero human data for 8141 means SRZN trades 100% on Merck&#39;s coattails this weekend.

StockTwits Web

Surrozen Inc

 .....Saturday AAO = binary moment. 
 
Merck’s Wnt data decides srzn fate for Monday: 
• Flop / toxic safety tables ➡️ dump to $10-$12 (PIPE floor) 
• Home run on vessel reperfusion ➡️ squeeze to $50+ 
 
Zero human data for 8141 means SRZN trades 100% on Merck's coattails this weekend.

val rusu

@GPRST Merck already published the most important data and we know it was a success. The &quot;negative&quot; safety can actually be a plus for us because it shows the need for VEGF inhibition which we have with SZN-8141. So if they show data that gives big pharma the conclusion that WNT activation plus VEGF inhibition could be the solution then we already have it. Also remigromig never showed a big effect on retinal reperfusion but Surrozen&#39;s WNT drugs showed a big effect there so that could be another positive for our drugs and Merck could be more interested to acquire Surrozen before telling this to everybody else publicly.

 Merck already published the most important data and we know it was a success. The "negative" safety can actually be a plus for us because it shows the need for VEGF inhibition which we have with SZN-8141. So if they show data that gives big pharma the conclusion that WNT activation plus VEGF inhibition could be the solution then we already have it. Also remigromig never showed a big effect on retinal reperfusion but Surrozen's WNT drugs showed a big effect there so that could be another positive for our drugs and Merck could be more interested to acquire Surrozen before telling this to everybody else publicly.

Peter

@BuyoutBobby ...That&#39;s a massive leap of logic. 
 
You can&#39;t brush off higher rates of vitreous bleeds and treatment dropouts as &quot;not important.&quot; Retinal specialists don&#39;t prescribe drugs that cause bleeds when Vabysmo and Eylea HD already have spotless safety profiles. 
 
If Wnt agonism is causing the vascular instability seen in BRUNELLO, tacking on anti-VEGF doesn&#39;t magically guarantee safety in humans. 
 
Merck paid up to $3B for EyeBio—they aren&#39;t rushing to buy out a pre-Phase 1 pipeline before seeing how the FDA interprets their own 1-year data. 
 
Saturday&#39;s granular safety tables dictate whether Big Pharma views Wnt as a breakthrough or a liability. Respect the risk.

 ...That's a massive leap of logic. 
 
You can't brush off higher rates of vitreous bleeds and treatment dropouts as "not important." Retinal specialists don't prescribe drugs that cause bleeds when Vabysmo and Eylea HD already have spotless safety profiles. 
 
If Wnt agonism is causing the vascular instability seen in BRUNELLO, tacking on anti-VEGF doesn't magically guarantee safety in humans. 
 
Merck paid up to $3B for EyeBio—they aren't rushing to buy out a pre-Phase 1 pipeline before seeing how the FDA interprets their own 1-year data. 
 
Saturday's granular safety tables dictate whether Big Pharma views Wnt as a breakthrough or a liability. Respect the risk.

@GPRST the thing is WNT activation itself probably doesn&#39;t trigger vascular instability because that doesn&#39;t make sense biologically. The higher rates of proliferative diabetic retinopathy and vitreous hemorrhage could be a problem of remigromig itself because it is not strong enough to trigger retinal reperfusion and not giving anti VEGF drugs to these people could also trigger these problems. Surrozen&#39;s WNT drug(SZN-8141) is different because first it triggers retinal reperfusion much more than remigromig and it also includes anti-VEGF with aflibercept sequences. I would say the remigromig results couldn&#39;t have been better for us and the detailed results will only prove more that a combination of WNT + VEGF could make a lot of sense.

 the thing is WNT activation itself probably doesn't trigger vascular instability because that doesn't make sense biologically. The higher rates of proliferative diabetic retinopathy and vitreous hemorrhage could be a problem of remigromig itself because it is not strong enough to trigger retinal reperfusion and not giving anti VEGF drugs to these people could also trigger these problems. Surrozen's WNT drug(SZN-8141) is different because first it triggers retinal reperfusion much more than remigromig and it also includes anti-VEGF with aflibercept sequences. I would say the remigromig results couldn't have been better for us and the detailed results will only prove more that a combination of WNT + VEGF could make a lot of sense.